Clinical Trial Update: Effects of Pravastatin on Cholesterol, Inflammation and Cognition in Schizophrenia [Phase 4]

View source ↗

Summary

Phase 4 clinical trial explored the effects of pravastatin on cholesterol, inflammation, and cognition in individuals with schizophrenia and related disorders. …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizoaffective Disorder
• Schizophrenia
• Schizophreniform Disorder

Drugs mentioned

• Pravachol (pravastatin)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Schizophrenia, Schizoaffective Disorders | Phase 4 | Status: COMPLETED | Results posted: 2014-04-28